Skip to content
-
Subscribe to our newsletter & never miss our best posts. Subscribe Now!
Itfy.in

At Itfy, we are dedicated to revolutionizing the way you receive news. Our mission is to provide timely, accurate, and personalized news updates using cutting-edge AI technology. Stay informed, stay ahead with us.

Itfy.in

At Itfy, we are dedicated to revolutionizing the way you receive news. Our mission is to provide timely, accurate, and personalized news updates using cutting-edge AI technology. Stay informed, stay ahead with us.

  • Home
  • News Updates
    • Latest News
    • Entertainment News
    • Northeast News
  • Technology
    • Digital Transformation
    • Artificial Intelligence
    • Machine Learning
    • Generative AI
    • Cybersecurity
  • Education & Growth
    • Education
    • Lifelong Learning
    • Parenting
    • Career Growth
  • Startup & Entrepreneurship
    • Remote Work
    • Startups
    • Digital Marketing
    • Social Media
    • Entrepreneurship
    • Lean Thinking
    • Personal Finance
  • Climate Justice
    • Climate Tech
  • Health & Wellness
    • Mental Health
  • Tourism
  • Home
  • News Updates
    • Latest News
    • Entertainment News
    • Northeast News
  • Technology
    • Digital Transformation
    • Artificial Intelligence
    • Machine Learning
    • Generative AI
    • Cybersecurity
  • Education & Growth
    • Education
    • Lifelong Learning
    • Parenting
    • Career Growth
  • Startup & Entrepreneurship
    • Remote Work
    • Startups
    • Digital Marketing
    • Social Media
    • Entrepreneurship
    • Lean Thinking
    • Personal Finance
  • Climate Justice
    • Climate Tech
  • Health & Wellness
    • Mental Health
  • Tourism
Close

Search

  • https://www.facebook.com/
  • https://twitter.com/
  • https://t.me/
  • https://www.instagram.com/
  • https://youtube.com/
Subscribe
Home/Latest News/Marksans Pharma Skyrockets by 16% to Hit Record Highs on Stunning Q1 Results | Market News
Latest News

Marksans Pharma Skyrockets by 16% to Hit Record Highs on Stunning Q1 Results | Market News

By adminitfy
August 14, 2024 2 Min Read

Marksans Pharma Shares Surge to Record High on Strong Q1FY25 Earnings

Published: Aug 14, 2024 | 2:13 PM IST | Last Updated: Aug 14, 2024 | 2:13 PM IST

Shares of Marksans Pharma soared 16% on the BSE, reaching an all-time high of Rs 217 during Wednesday’s intra-day trading session, driven by the company’s robust performance in the June 2024 quarter (Q1FY25). By 1:49 PM, the stock was trading at Rs 216.35, reflecting a 15% gain compared to a modest 0.24% rise in the BSE Sensex. The trading volumes surged more than three-fold, with 16 million shares traded across the NSE and BSE.

The pharmaceutical firm’s revenue for Q1FY25 grew by 18% year-on-year (YoY) to Rs 590.60 crore, while earnings before interest, tax, depreciation, and amortization (EBITDA) increased by 26% YoY to Rs 128.4 crore. The EBITDA margin also improved from 20.4% in Q1FY24 to 21.7%. The company reported a substantial 26.5% YoY increase in profit after tax, amounting to Rs 89.1 crore.

Notably, the US and North America formulation business saw a 29.8% YoY growth, reaching Rs 250.90 crore, driven by new product launches and increased orders from existing customers. Marksans Pharma indicated a promising pipeline of 32 products, consisting of 20 oral solids, 12 ointments and creams, including 4 Softgels.

Management attributed the impressive quarterly growth to a marked increase in contributions from existing customers and new product launches. Although favorable raw material prices benefited the company, higher freight costs persisted.

With shipments from a new facility underway to key markets, Marksans Pharma remains optimistic about achieving stronger performance in upcoming quarters and aims to reach a revenue milestone of Rs 3,000 crore within the next two years.

Marksans Pharma specializes in the research, manufacturing, and marketing of generic pharmaceutical formulations worldwide. Its facilities are approved by major regulatory agencies such as the USFDA, UKMHRA, and Australian TGA. The company’s diverse product portfolio covers essential therapeutic segments like cardiovascular, central nervous system, antidiabetic, pain management, gastroenterological, and anti-allergies.

First Published: Aug 14, 2024 | 2:10 PM IST

Original Story https://www.business-standard.com/markets/news/marksans-pharma-zooms-to-record-high-stock-up-on-strong-q1-results-124081400906_1.html
Category :
Tags:

Author

adminitfy

Follow Me
Other Articles
Previous

Passenger Vehicle Wholesales Plunge 2.5% in July: Unstoppable Retail Inventory Surge!

Next

UK Inflation Skyrockets in July 2024: Shocking Surge Stirs Widespread Concern

Search...

Recent Posts

  • PM Modi Opens SCO Civilisational Forum, Says Culture Guarantees Peace
    PM Modi Opens SCO Civilisational Forum, Says Culture Guarantees Peace
    by adminitfy
    November 21, 2026
  • Empowering Northeast India: CII’s CSR Connect Event Ignites Social Development
    by adminitfy
    July 3, 2024
  • Urgent Crisis: Northeast on High Alert as Death Toll Tragically Rises in Assam
    by adminitfy
    July 3, 2024
  • Triumphant Breakthrough: Security Forces Successfully Capture 4 Insurgents in Manipur Operation
    by adminitfy
    July 3, 2024

Welcome to the ultimate source for fresh perspectives! Explore curated content to enlighten, entertain and engage global readers.

  • Facebook
  • X
  • Instagram
  • LinkedIn

Latest Posts

  • PM Modi Opens SCO Civilisational Forum, Says Culture Guarantees Peace
  • Trump Urges Nvidia to Give Jensen Huang a Second Chance
  • The Evaluation Frontier: Measuring AI on Judgment-Heavy R&D
  • Assam: AJYCP Protests Over Alleged Illegal Timber, Mineral Extraction
  • Amit Shah in Arunachal for 2-Day Visit; Itanagar Security Tightened
  • November 2026 (640)
  • October 2026 (646)
  • September 2026 (524)
  • August 2026 (1001)
  • July 2026 (986)
  • June 2026 (963)
  • May 2026 (922)
  • April 2026 (1525)
  • March 2026 (1522)
  • February 2026 (1252)
  • January 2026 (968)
  • December 2025 (942)
  • November 2025 (853)
  • October 2025 (869)
  • September 2025 (733)
  • August 2025 (810)
  • July 2025 (720)
  • June 2025 (1244)
  • May 2025 (2201)
  • April 2025 (1481)
  • March 2025 (2020)
  • February 2025 (1159)
  • January 2025 (1440)
  • December 2024 (1499)
  • November 2024 (1771)
  • October 2024 (1815)
  • September 2024 (1750)
  • August 2024 (1458)
  • July 2024 (1268)

Contact

Email

info@itfy.in

Location

INDIA

Copyright 2026 — Itfy.in. All rights reserved.